OncoArendi Therapeutics Overview

  • Founded
  • 2012
Founded
  • Status
  • Public
  • Employees
  • 86
Employees
  • Stock Symbol
  • OAT
Stock Symbol
  • Share Price
  • $13.53
  • (As of Friday Closing)

OncoArendi Therapeutics General Information

Description

Oncoarendi Therapeutics SA is a biopharmaceutical company engaged in discovering, developing and commercializing novel therapeutics for neoplastic and inflammatory diseases. The company is focused on discovering and developing molecules with potential to become first-in-class or best-in-class drugs worldwide to treat unmet medical needs.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
WAR
Primary Office
  • Żwirki i Wigury 101
  • Warszawa, 02-089
  • Poland
+48 22 000 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

OncoArendi Therapeutics Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$13.53 $13.20 $1.96 - $21.22 $188M 13.9M 43.7K -$0.06

OncoArendi Therapeutics Financials Summary

In Thousands,
USD
TTM 30-Sep-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 57,834 26,391 36,360
Revenue 1 1 1 2
EBITDA (875) (1,197) (1,406) (671)
Net Income (862) (1,085) (1,231) (636)
Total Assets 21,218 22,558 22,857 9,930
Total Debt 748 1,007 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

OncoArendi Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore OncoArendi Therapeutics‘s full profile, request access.

Request a free trial

OncoArendi Therapeutics Executive Team (3)

Name Title Board Seat Contact Info
Marcin Szumowski Chief Executive Officer & President
Sławomir Broniarek Chief Financial Officer & Board Member
Stanisław Pikul Ph.D Co-Founder, Vice President, Development & Board Member
To view OncoArendi Therapeutics’s complete executive team members history, request access »

OncoArendi Therapeutics Board Members (2)

Name Representing Role Since
Sławomir Broniarek OncoArendi Therapeutics Chief Financial Officer & Board Member 000 0000
Stanisław Pikul Ph.D OncoArendi Therapeutics Co-Founder, Vice President, Development & Board Member 000 0000
To view OncoArendi Therapeutics’s complete board members history, request access »

OncoArendi Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial